NCT06090630View on ClinicalTrials.gov

MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

February 3, 2023

Study Completion Date

February 3, 2023

Conditions
Benign Breast NeoplasmBreast CarcinomaMalignant Breast Neoplasm
Interventions
PROCEDURE

Diffusion Weighted Imaging

Undergo DWI-MRI

PROCEDURE

Magnetic Resonance Spectroscopic Imaging

Undergo MR spectroscopic imaging

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

U.S. Army Medical Research and Development Command

FED

collaborator

U.S. Army Medical Research Acquisition Activity

FED

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT06090630 - MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer | Biotech Hunter | Biotech Hunter